SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD)
ACAD 22.70-0.2%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (512)9/3/2008 9:49:14 PM
From: Biotech Jim   of 588
 
<Stuff continues to come out with Brann's name on it, though it's been . . . what . . . two years? That's how long it takes this kind of research to work its way into print.>

In my experience and in speaking with several colleagues at companies like MRK, PFE, SNY, JNJ and others, the time frame for writing up and publishing such work is from 2-6 years, depending on whether the lead compound from the series is progressing in development. If it is, then the company may wait until Ph 2b or Ph 3 fro the publication. In fact, some of my PFE friends say that only the dead end leads are published.

BJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News